SNPX - synaptogen.com Uzoq muddatli majburiyatlarning kapitalga nisbati

Synaptogenix, Inc. (SNPX) tovar belgisi

Synaptogenix, Inc. (SNPX) — bu hali daromadli bo‘lmagan va sanoat gigantlaridan alohida resurslar uchun raqobatlashayotgan mikro-kapitallizatsiyali biotexnologiya kompaniyasidir. Biznes neyron aloqalarining tiklanishini ta'minlovchi demensiya davolash vositasini ishlab chiqishga tayanadi. GURU.Markets platformasida mavjud narx harakati vektori 0.00 darajasida qayd etilgan. Eksklyuziv terapiya huquqlari va lobbiistlarning qo‘llab-quvvatlashi FDA ning qat'iy nazoratiga qaramay loyihani himoya qiladi.

SNPX - Synaptogenix Inc. Uzoq muddatli qarzning o'z kapitaliga nisbati 04.07.2022 - 02.05.2026 oraligʻida

Synaptogenix, Inc. (SNPX) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kursi Synaptogenix Inc.|SNPX - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Synaptogenix, Inc.|SNPX - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Synaptogenix|SNPX - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati synaptogen.com|SNPX - Kompaniyaning jami aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning kapitalga nisbati Synaptogenix, Inc.|SNPX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti synaptogen.com|SNPX - Kompaniyaning umumiy qarzi|Balans qiymatiga qarzlar Synaptogenix, Inc.|SNPX - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Synaptogenix
Kompaniyaning jamlanma tahliliyoti:Synaptogenix Inc.
Synaptogenix brendining mahsuloti

Ko'rsatkich uzoq muddatli majburiyatlarning kapitalga nisbati sifatida hisoblanadi. Ushbu metrika moliyaviy leveraj darajasini aniqlab, kompaniyaning uzoq muddatli rejalashtirishda qarzga bo'lgan bog'liqligini baholaydi. Synaptogenix, Inc. uchun bu ilmiy sherikliklar orqali Bryostatin-1 ishlanmalarini moliyalashtirishda juda muhimdir. Uzoq muddatli qarzning moliyaviy leveraj tarixini tahlil qilish orqali investor haddan tashqari qarz yuklamasi yoki aktivlarning haddan ortiq baholanishi xatarlarini aniqlashi mumkin.

Synaptogenix, Inc. raqobatchilari

Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Biogen Inc|Neurocrine Biosciences Inc - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Regencell Corp RGC|Uzoq muddatli qarzning o'z kapitaliga nisbati AXSM (Axsome Therapeutics)|acadia-pharm.com - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Xenon (XENE)|VKTX: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati SUPN|CPRX (Catalyst Corp) - Uzoq muddatli majburiyatlarning kapitalga nisbati|DNLI: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati harmonybiosciences.com (HRMY)|Biohaven - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati AMLX (Amylyx Pharmaceuticals Inc)|TRVI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Praxis Corp PRAX|Anavex Life Sciences - Uzoq muddatli qarzning kapitalga nisbati|CBLL: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Prothena Corp (PRTA)|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati Alector|Annexon Inc. (ANNX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati OMER|Neurogene Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati acimmune.com (ACIU)|VYGR (Voyager Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati Neumora NMRA|SCLX (Scilex Holding Co.) - Uzoq muddatli qarzning kapitalga nisbati|TVGN: Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati alphacognition.com|cogrx.com (CGTX) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|IKT: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Cassava Sciences Inc (SAVA)|Uzoq muddatli qarzning o'z kapitaliga nisbati Assertio Holdings, Inc. ASRT|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi coyatherapeutics.com COYA|Uzoq muddatli qarzning o'z kapitaliga nisbati Vistagen|Uzoq muddatli qarzning kapitalga koeffitsiyenti Ovid Therapeutics Inc OVID|Uzoq muddatli qarzning kapitalga nisbati ABOS (Acumen Pharmaceuticals, Inc.)|CRVO: Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati alteritytherapeutics.com|Clene (CLNN) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati PEPG|Uzoq muddatli qarzning o'z kapitaliga nisbati jupiterneurosciences.com (JUNS)|RLMD (Relmada Therapeutics, Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati ANVS (Annovis Bio Inc)|Uzoq muddatli qarzning o'z kapitaliga nisbati GRCE|Firefly Neuro - Uzoq muddatli qarzdorlikning kapitalga nisbati|ANEW Medical, Inc. (KLTO) - Uzoq muddatli qarzning o'z kapitaliga nisbati|NRSN: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning o'z kapitaliga nisbati Reviva Pharmaceuticals Holdings, Inc. (RVPH)|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati MetaVia|Uzoq muddatli qarzning o'z kapitaliga nisbati NeurAxis, Inc (NRXS)|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi HSDT|Uzoq muddatli qarzning o'z kapitaliga nisbati Passage Bio, Inc. PASG|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi bionomics.com.au (NEUP)|NERV: Uzoq muddatli qarzning kapitalga nisbati|ATHA - Uzoq muddatli majburiyatlarning kapitalga nisbati|Addex Therapeutics, Ltd. - Uzoq muddatli qarzning o'z kapitaliga nisbati|ALZN: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati cyclerion.com CYCN|PTIX (Protagenic Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati KTTA (Pasithea Therapeutics Corp)|Uzoq muddatli majburiyatlarning kapitalga nisbati CRGT|ATXI (Avenue Therapeutics, Inc) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati BrainStorm Cell Therapeutics Inc. BCLI|CARA: Uzoq muddatli qarzning o'z kapitaliga nisbati|chromocell.com - Uzoq muddatli majburiyatlarning kapitalga nisbati|Eliem (ELYM) - Uzoq muddatli qarzning o'z kapitaliga nisbati|ITCI - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|LBPH: Uzoq muddatli qarzning kapitalga nisbati|MRNS (Marinus Pharma) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati NKGen Biotech, Inc. NKGN|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati neurobopharma.com (NRBO)|Uzoq muddatli qarzning o'z kapitaliga nisbati Sage Therapeutics|Uzoq muddatli kreditlarning kapitalga nisbati TRVN (Trevena Inc.)|VIGL: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Anew Medical Inc. WENA|Uzoq muddatli qarzning kapitalga nisbati CERE